In the first issue of the Annals of Pharmacotherapy (AOP), which was originally titled simply as Drug Intelligence back in January 1967, founding editor Donald E. Francke described the Journal and its goals:
• • "An independent journal . . . not restricted in what it may publish by the policy of any organization" • • "Will strive to provide an exchange of information and practices on an international scale . . ." • • "To make pharmacists more sophisticated in their knowledge of drugs and thus to enhance their ability to make intelligent judgments regarding their properties and characteristics, . . ." • • "Pharmacists must be encouraged to relate to the patent, the physician, and the nurse and to take his place on the health-care team as practitioner of clinical pharmacy . . ." • • "To encourage the development of specialization . . ."
• • "To encourage the profession to extend its services to small hospitals, extended care facilities, and nursing homes where it is so greatly needed . . ." • • "To stimulate . . . teaching and research activities . . ." 1 With this issue, AOP begins its 50th year of publication. It would seem like an opportune time to not only recognize this achievement but to reflect on and assess how the Journal has remained true to Dr Francke's original vision for the Journal. This past half century has seen remarkable progress in the discipline of clinical pharmacy, all of which has been recorded and reported in numerous articles published in AOP over this period. However, what has the Journal done and how has it grown to welcome changes while continuing to achieve the original goals?
When AOP debuted in 1967 under the title of Drug Intelligence (the Journal has had several names, the duration and history of which have previously been extensively detailed 2-5 ), clinical pharmacy was not a widely accepted discipline. Indeed, many health care professionals questioned the need of pharmacists to be involved in anything more than formulating and dispensing the prescribed medications. 6 Clinical pharmacy services are now an accepted and integral part of our health care system. Given today's perspective of the range, breadth, and depth of knowledge of clinical pharmacists, it is difficult to imagine this time not so long ago when the benefits of these pharmacotherapy specialists were not utilized to their fullest. Of course, we have the benefit of hindsight here, whereas the "pioneers" of clinical pharmacy had the initiative, confidence, and perseverance to determine the best course and used their knowledge and skills to have an impact on patient care.
The content of AOP has evolved over time in parallel with pharmacotherapy and has featured current and emerging areas or trends of interest in medication use to its readers. 7 The Journal was among the first to emphasize biopharmaceutics, pharmacodynamics, and pharma-cokinetics 8, 9 ; the role of drug information centers to disseminate important medication-related material to in-house or other health care professionals 10, 11 ; the importance and significance of medication errors 12 ; drug interactions 13 ; pharmacoeconomics 14 ; pharmacoepidemiology 15 ; pharma-cogenetics 16 ; and the education, duties, roles, and responsibilities of pharmacy technicians. [17] [18] [19] These are but a few of the topics published in the Journal that may have been our readers' first introductions to these newly prominent areas of practice.
The editorial board of the Journal has also evolved alongside clinical pharmacy over this time. Expansion of pharmacy specialization has been paralleled by similar increases in the number and category of specialized editorial board panels needed to assess, critique, and evaluate manuscripts in these new areas.
The first retrospective celebration of AOP was its 25th anniversary, which occurred in 1991. In looking at the cover listings of articles and authors during that year, it is noteworthy that many of the authors of those articles continue to be active practitioners, educators, researchers, authors, editorial board members, and reviewers for the Journal today. Their longevity speaks to the long-lasting impact they and others have had on patient care, and their efforts in educating and training students, residents, and fellows ensure that the practice of clinical pharmacy will continue to advance in the future.
Alongside these clinical pharmacy veterans, our editorial board also features many younger practitioners who are distinguishing themselves in their specialty areas. We owe a huge debt to our editorial board members and manuscript reviewers, who through the years have assisted in the decision-making process of material published in AOP. Our annual assessment of the editorial board and reviewers ensures continued quality and effectiveness to meet our needs in various therapeutic areas.
A larger retrospective celebration was done to commemorate the 40th anniversary of the Journal during 2006-2008. We captured advances in clinical pharmacy and pharmacotherapy, with publication of many editorials and reprints of landmark articles that had appeared earlier in the Journal. These editorials, recollections, and key articles were even compiled in a book, providing a remarkable story of clinical pharmacy as reflected by AOP content over this time. 2, [5] [6] [7] 10 Of course the Journal would not exist without the submissions of manuscripts offered by authors from the United States and abroad. These submissions keep AOP relevant and in the forefront of clinical pharmacy and pharmacotherapy publications. Our authors' professional expertise in furthering pharmacotherapeutic information to others has provided the Journal with quality content that is of great interest to health professionals. This has been reflected in the Journal's impact factor, which has consistently placed it in the top tiers of pharmacy journals.
It is gratifying that the number of submissions to the Journal has continued on its upward trend to the present day. This allows us to be more selective of those articles with high relevancy for publication and maintain reasonable issue sizes for our readers. This too reflects the strength of our discipline as more authors seek to disseminate their research and review articles to the growing audience in health care. We are pleased to have AOP as the platform or venue from which such work has been made available to all.
An important goal of the Journal has been to not only be a platform to publish cutting edge drug therapy research or state-of-the-art reviews, but to also be a forum for the exchange of ideas related to pharmacotherapy and clinical pharmacy. In this regard, we have continued to welcome emerging topics in the form of well-reasoned therapeutic controversies or commentaries. In addition, letters to the editor make for interesting reading.
Naturally, the overall direction of the Journal has been the responsibility of the editor. As noted above, Dr Francke was the first editor of AOP, and he held this title from the inaugural issue in January 1967 through to his untimely death in late 1978. In taking over from Dr Francke, the Journal's assistant editor Harvey A. K. Whitney Jr then guided the Journal for over a quarter of a century through the end of 2005, at which time he became editor emeritus. Both these individuals made immense contributions to AOP. We in the roles of editor-in-chief and managing editor express our gratitude to them and feel honored to continue to advance the tradition of excellence for AOP.
Accessibility of the Journal to its readers continues to improve. When the Journal began in 1967, the only way to read its articles was to acquire a printed copy of the Journal or request a reprint from the author or publisher. The Journal has kept up with the times in today's world of instant communication, and articles are now available as quickly as they are published via the AOP OnlineFirst feature. Journal content now meets the need for instant accessibility. Articles are promoted on Twitter and can be accessed online via computers, tablets, and mobile devices.
AOP has been a part of medical publishing for 50 years. There still may be practitioners who can remember the time before there was AOP. However, we hope that current clinicians will never know a time when they will not have instant access to present and past articles of the Journal as needed in their professional work.
We have reviewed some of the Journal's past and its current status. What can our readers expect in the future? We look forward to publishing impactful research and review articles emanating from the enormous changes occurring in our health care environment. The increasing burden of chronic diseases associated with rising life expectancy, complexities of medications (eg, biologics and targeted therapies), high cost of medications, shift from volume-to value-based payments or from fee-for-service to bundled payments, and health care regulations, including the Affordable Care Act, will require publication of welldesigned research and comprehensive reviews to recommend the most cost-effective therapies for patients. It is refreshing to observe the evolving roles of pharmacists in disease and medication therapy as well as in wellness and disease prevention. 20 SAGE Publications assumed the role of publisher of AOP in 2013, 3 and the Journal is available worldwide online and in print. The support of the publisher will strengthen the Journal as a result of adoption of new technologies and methods of dissemination, which will provide increased user reach and convenience over the coming years.
There have been many advances in clinical pharmacy and pharmacotherapy over the past 50 years. AOP will continue to embrace progress in our pharmacotherapy and health care through publication of high-quality articles. As editors, we feel privileged to have witnessed the growth and unique contributions of pharmacy to health care at the time of the Journal's golden anniversary. We are grateful to all our contributors and publishers and look forward to working with you to continue to offer the best information to achieve the maximum benefits of pharmacotherapy at the lowest costs to our society.
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